Ignite Creation Date:
2025-12-24 @ 9:15 PM
Ignite Modification Date:
2026-04-13 @ 12:06 PM
Study NCT ID:
NCT05521204
Status:
RECRUITING
Last Update Posted:
2022-08-30
First Post:
2022-08-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Olverembatinib for FGFR1-rearranged Neoplasms
Sponsor:
Organization: